Zobrazeno 1 - 10
of 64
pro vyhledávání: ''
Publikováno v:
Cancer Biomarkers. 32:559-567
BACKGROUND: CA125 level normalization at different chemotherapy cycles has been reported to be a prognosticator in advanced epithelial ovarian cancer. OBJECTIVE: In the present study, we investigated whether the time (in days) to CA125 normalization
Autor:
Linu Abraham Jacob, M C Suresh Babu, Smitha Saldanha, L K Rajeev, A H Rudresha, K N Lokesh, Usha Amirtham, A. Thottian, D. Lokanatha, Shina Goyal
Publikováno v:
Breast Disease. 41:115-121
BACKGROUND: The present era of individualized treatment for breast cancer is influenced by the initial disease status including the anatomical extent, grade, and receptor status. An accurate preoperative staging is the basis of treatment planning and
Autor:
Carissa Laboy, Luis Z. Blanco, Rachel Brancamp, Brian S. Finkelman, Kalliopi P. Siziopikou, Amanda Meindl, Brannan B. Griffin, Jennifer L. Pincus, Suguna P. Narayan
Publikováno v:
Breast Disease. 41:55-65
BACKGROUND: Ki-67 immunohistochemistry (IHC) staining is a widely used cancer proliferation assay; however, its limitations could be improved with automated scoring. The OncotypeDXTM Recurrence Score (ORS), which primarily evaluates cancer proliferat
Autor:
Chloe Nielsen, Sarah J. Egan, Natalie Gasson, Andrea M. Loftus, Sergio E. Starkstein, Emily J. Corti
Publikováno v:
Journal of Parkinson's Disease. 11:2017-2026
Background: Recent research suggests that a significant number of those who receive advanced treatments for Parkinson’s disease (PD) do not report improvements for some symptoms, which may relate to their pre-treatment expectations. It is important
Autor:
Atanas Ignatov, Piotr Czapiewski, Thomas Kalinski, Willi Pieper, Norbert Nass, Johannes Haybaeck
Publikováno v:
Cancer Biomarkers. 32:161-173
BACKGROUND: Neuronatin (NNAT) determined by immunohistochemistry is a negative prognostic biomarker for breast cancer, independent of the major clinicopathological markers. OBJECTIVE: Here, we investigated whether NNAT is also a predictive biomarker
Publikováno v:
Journal of Back and Musculoskeletal Rehabilitation. 34:485-490
BACKGROUND: Myofascial Pain Syndrome causes disability in daily life activities and despite all efforts, it continues to be a challenge, perpetuating suffering, overloading services and costs. New treatment options need to be tested. OBJECTIVE: We ai
Publikováno v:
Breast Disease. 40:25-31
AIM OF THE STUDY: The microenvironment depicts the relationship between tumour cells and immune response, and every insight into stromal lymphocytes could contribute to explain their role and activity. E26 transformation specific-1 (ETS-1) is a trans
Publikováno v:
Journal of Neuromuscular Diseases. 8:299-303
The prognostic value of cerebrospinal fluid (CSF) protein in Guillain Barré Syndrome (GBS) is unclear. We aimed to explore the potential association between CSF protein level and mechanical ventilation in GBS. We undertook a retrospective study of G
Publikováno v:
Cancer Biomarkers. 29:387-397
BACKGROUND: The runt-related transcription factor family (RUNXs) including RUNX1, RUNX2, and RUNX3 are key transcriptional regulators in normal hematopoiesis. RUNXs dysregulations caused by aberrant expression or mutation are frequently seen in vario
Publikováno v:
Restorative Neurology and Neuroscience. 38:265-270
Objective: This study aimed to analyze the correlation between platelet (PLT) count and the modified Rankin scale (mRS) in patients with cerebral infarction (CI) at the later stage of rehabilitation, which can be used to guide the secondary preventio